A Large Family with p.Arg554His Mutation in ABCD1: Clinical Features and Genotype/Phenotype Correlation in Female Carriers
Authors:
- Rosa CampopianoRCRosa Campopiano
- Cinzia FemianoCFCinzia Femiano
- Maria Antonietta ChiaravallotiMCMaria Antonietta Chiaravalloti
- Rosangela FereseRFRosangela Ferese
- Diego CentonzeDiego Centonze
- Fabio ButtariFBFabio Buttari
- Stefania ZampattiSZStefania Zampatti
- Mirco FanelliMFMirco Fanelli
- Stefano AmatoriStefano Amatori
- Carmelo D’alessioCDCarmelo D’alessio
- Emiliano GiardinaEGEmiliano Giardina
- Francesco FornaiFrancesco Fornai
Open Access
Abstract
X-linked adrenoleukodystrophy (X-ALD, OMIM #300100) is the most common peroxisomal disorder clinically characterized by two main phenotypes: adrenomyeloneuropathy (AMN) and the cerebral demyelinating form of X-ALD (cerebral ALD). The disease is caused by defects in the gene for the adenosine triphosphate (ATP)-binding cassette protein, subfamily D (ABCD1) that encodes the peroxisomal transporter of very-long-chain fatty acids (VLCFAs). The defective function of ABCD1 protein prevents β-oxidation of VLCFAs, which thus accumulate in tissues and plasma, to represent the hallmark of the disease. As in many X-linked diseases, it has been routinely expected that female carriers are asymptomatic. Nonetheless, recent findings indicate that most ABCD1 female carriers become symptomatic, with a motor disability that typically appears between the fourth and fifth decade. In this paper, we report a large family in which affected males died during the first decade, while affected females develop, during the fourth decade, progressive lower limb weakness with spastic or ataxic-spastic gait, tetra-hyperreflexia with sensory alterations. Clinical and genetic evaluations were performed in nine subjects, eight females (five affected and three healthy) and one healthy male. All affected females were carriers of the c.1661G>A (p.Arg554His, rs201568579) mutation. This study strengthens the relevance of clinical symptoms in female carriers of ABCD1 mutations, which leads to a better understanding of the role of the genetic background and the genotype-phenotype correlation. This indicates the relevance to include ABCD1 genes in genetic panels for gait disturbance in women.Keywords
This publication has 39 references indexed in Scilit:
- Mutations, Clinical Findings and Survival Estimates in South American Patients with X-Linked AdrenoleukodystrophyPLOS ONE, 2012
- X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and managementOrphanet Journal of Rare Diseases, 2012
- X-linked adrenoleukodystrophy: Diagnostic and follow-up system in JapanJournal of Human Genetics, 2010
- Phenotypes of female adrenoleukodystrophyNeurology, 2007
- ABCD1 Gene Mutations in Chinese Patients With X-Linked AdrenoleukodystrophyPediatric Neurology, 2005
- Decreased expression of ABCD4 and BG1 genes early in the pathogenesis of X-linked adrenoleukodystrophyHuman Molecular Genetics, 2005
- X‐linked adrenoleukodystrophy in Spain. Identification of 26 novel mutations in the ABCD1 gene in 80 patients. Improvement of genetic counseling in 162 relative femalesClinical Genetics, 2005
- ABCD1 mutations and the X-linked adrenoleukodystrophy mutation database: Role in diagnosis and clinical correlationsHuman Mutation, 2001
- Assessment of Adrenal Function in Women Heterozygous for AdrenoleukodystrophyThe Journal of Clinical Endocrinology & Metabolism, 1997
- Clinical Aspects of Adrenoleukodystrophy and AdrenomyeloneuropathyDevelopmental Neuroscience, 1991